The result from a follow-up study of 136 patients with DOCK8 deficiency showed that 23 patients (17%) were diagnosed with malignant tumors, including 11 cases of hematological cancer, 9 cases of epithelial cancer and 5 cases of other malignant tumors (Aydin et al., 2015). Here, DOCK8 is linked to cancer.